Addus HomeCare Corporation (ADUS) vs Celldex Therapeutics, Inc. (CLDX)
A side-by-side comparison of Addus HomeCare Corporation and Celldex Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ADUS
Addus HomeCare Corporation
$112.98HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
CLDX
Celldex Therapeutics, Inc.
$32.59HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ADUS vs CLDX
growth of $100 · dividends reinvested · last 10yADUS +316.7% (+15.3%/yr)CLDX -49.1% (-6.5%/yr)ADUS compounded faster over this window
Log scale — wide-divergence pair
ADUS CLDX
ADUS vs CLDX: by the numbers
- •CLDX is the larger company ($2.17B vs $2.11B market cap).
- •ADUS is profitable (7.13% net margin) while CLDX runs a net loss (-268385.71%).
- •ADUS grew revenue faster over the past five years (12.67% vs -58.05% CAGR).
Metrics side by side
Valuation
| Metric | ADUS | CLDX |
|---|---|---|
| P/E ratio | 19.82 | N/A |
| Forward P/E | 16.03 | N/A |
| PEG ratio | 0.98 | N/A |
| P/S ratio | 1.43 | 19361.50 |
| P/B ratio | 1.84 | 3.03 |
| EV / EBITDA | 12.84 | N/A |
| FCF yield | 7.26% | N/A |
Profitability
| Metric | ADUS | CLDX |
|---|---|---|
| Gross margin | 32.36% | 100.00% |
| Operating margin | 10.04% | -19160.00% |
| Net margin | 7.13% | -268385.71% |
| ROE | 9.17% | -42.07% |
| ROIC | 8.61% | -45.19% |
Growth (annualized)
| Metric | ADUS | CLDX |
|---|---|---|
| Revenue CAGR (5Y) | 12.67% | -58.05% |
| EPS CAGR (5Y) | 19.61% | N/A |
| FCF CAGR (5Y) | 24.41% | N/A |
| Total return CAGR (5Y) | 8.33% | -10.28% |
Frequently asked
- Which has grown faster, ADUS or CLDX?
- Over the past five years, ADUS grew revenue faster — ADUS at a 12.67% CAGR versus CLDX at -58.05%.
- Is ADUS or CLDX more profitable?
- ADUS runs the higher net margin — ADUS at 7.13% versus CLDX at -268385.71%.
- How have ADUS and CLDX total returns compared?
- Over the past 10 years, ADUS delivered 15.62% and CLDX delivered -6.79% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Addus HomeCare P/E ratioAddus HomeCare ROECelldex Therapeutics ROEAddus HomeCare operating marginCelldex Therapeutics operating marginAddus HomeCare revenue growthCelldex Therapeutics revenue growthAddus HomeCare free cash flowCelldex Therapeutics free cash flow
Addus HomeCare & Celldex Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.